GMED
Globus Medical, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.5% ·
aandelenstroom -3.4% ·
netto nieuwe posities +4.3%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 121 | -3 | 71.19M | $5.65B | +7 | −11 |
| Q1 2026 | 128 | +3 | 69.73M | $6.00B | +7 | −5 |
| Q4 2025 | 125 | -2 | 72.17M | $6.30B | +1 | −2 |
| Q3 2025 | 23 | +2 | 41.89M | $2.40B | +2 | −1 |
| Q2 2025 | 19 | -2 | 35.55M | $2.10B | — | −2 |
| Q1 2025 | 18 | +2 | 12.57M | $919.97M | +3 | −1 |
| Q4 2024 | 16 | 0 | 17.69M | $1.46B | +1 | −1 |
| Q3 2024 | 15 | 0 | 11.77M | $842.11M | +1 | −1 |
| Q2 2024 | 15 | — | 12.93M | $885.43M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 10.61M | -1.0% | $607.39M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 10.53M | -2.1% | $603.24M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 3 | JPMorgan Chase ✦ | 7.36M | — | $421.73M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 4 | State Street Global Advisors ✦ (passief) | 3.46M | -0.3% | $198.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 2.06M | +3.5% | $118.17M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Marshall Wace ✦ | 1.71M | +8.3% | $98.04M | 0.1% | ▲ Add | 6 | SEC ↗ ×3 |
| 7 | T. Rowe Price ✦ | 1.09M | +1.6% | $62.52M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 865.56K | -56.0% | $49.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 841.00K | — | $48.16M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 10 | Goldman Sachs Group ✦ | 767.56K | — | $43.96M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 11 | Capital World Investors ✦ | 574.50K | 0.0% | $32.90M | 0.0% | Held | 6 | SEC ↗ |
| 12 | Bridgewater Associates ✦ | 461.09K | +5.6% | $26.41M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | Millennium Management ✦ | 357.76K | +945.1% | $20.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 243.92K | +131.4% | $13.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 215.35K | +108.1% | $12.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 206.17K | Nieuw | $11.81M | 0.0% | New | 1 | SEC ↗ |
| 17 | GAMCO Investors ✦ | 134.73K | -0.4% | $7.72M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 112.09K | Nieuw | $6.42M | 0.0% | New | 1 | SEC ↗ ×2 |
| 19 | Gotham Asset Management ✦ | 109.33K | -55.2% | $6.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 75.51K | -32.6% | $4.24M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 21 | Fidelity (FMR) ✦ | 48.17K | -93.7% | $2.76M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 22 | PRIMECAP Management ✦ | 34.12K | -4.2% | $1.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 9.95K | -96.5% | $569,892 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| D. E. Shaw & Co. | $11.81M | 0.0% |
| Citadel Advisors | $6.42M | 0.0% |
Verlaten
| Norges Bank | $68.04M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 598 houders, 106.58M aandelen, $8.83B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 30.00K aand · $2.24M
Director · 25.00K aand · $2.18M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie